Search within:  

Sort results by:      



1-20 of 1191   Next >
 
1.  
Advance directives. In: Evidence-based geriatric nursing protocols for best practice. 2003 (revised 2012). NGC:009703
Hartford Institute for Geriatric Nursing - Academic Institution. View all guidelines by the developer(s)
2.  
Advance care planning. 2012 Jan (revised 2014 Jan). NGC:010232
Michigan Quality Improvement Consortium - Professional Association. View all guidelines by the developer(s)
4.  
Heart failure in adults. 1997 Oct (revised 2013 Jul). NGC:009982
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
5.  
Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation. 2011 Dec. NGC:009031
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
Health maintenance in the long term care setting. 2007 (revised 2012). NGC:009845
American Medical Directors Association - Professional Association. View all guidelines by the developer(s)
7.  
9.  
10.  
Eribulin for the treatment of locally advanced or metastatic breast cancer. 2012 Apr. NGC:009074
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
11.  
Pembrolizumab for advanced melanoma not previously treated with ipilimumab. 2015 Nov 25. NGC:010860
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
12.  
Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma. 2014 Jul. NGC:010497
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
13.  
Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma. 2012 Dec. NGC:009517
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
14.  
Everolimus in combination with exemestane for treating advanced HER2-negative hormone-receptor-positive breast cancer after endocrine therapy. 2013 Aug. NGC:010011
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
15.  
Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer. 2013 May. NGC:009894
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
16.  
Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer. 2013 May. NGC:009893
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
17.  
Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract. 2013 Jan. NGC:009632
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
18.  
Targeted therapy for locally advanced unresectable or metastatic medullary thyroid carcinoma. 2012 Nov. NGC:010382
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
19.  
Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab. 2015 Oct 7. NGC:010817
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
20.  
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer. 2014 Apr. NGC:010348
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
1-20 of 1191   Next >